AS ONE Corporation
As ONE Corporation Fiscal Year Ending March 2026 Financial Results | Sales of 110.6 billion yen (+6.7% YoY)
As ONE's fiscal year ending March 2026 resulted in record-high sales of 110.6 billion yen (+6.7% YoY) and operating profit of 12.8 billion yen (+10.7%), maintaining steady performance driven by post-COVID medical and research demand.
Key Figures
- Sales: 110.6 billion yen (YoY +6.7%)
- Operating profit: 12.8 billion yen (YoY +10.7%)
- Net income: 9.179 billion yen (YoY +11.5%)
AI要約
Performance Overview
As ONE's fiscal year ending March 2026 achieved record-high sales of 110.6 billion yen (YoY +6.7%) and operating profit of 12.8 billion yen (+10.7%), reflecting steady growth driven by expanding demand in medical and research fields, with a continued recovery trend post-COVID. The increase in sales was primarily due to strong performance in research equipment and medical-related products, with improved profit margins.
Outlook and Investor Impact
Looking ahead, sustained growth is expected backed by expanding demand in medical and research sectors. The company is actively advancing new businesses and international expansion, promising medium- to long-term growth. For investors, the company offers a stable earnings base and growth potential, with prospects for stock price appreciation and increased dividends.
As ONE Corporation
Company overview · Stock price · Financial data · All IR
